🇺🇸 FDA
Patent

US 10653778

Compositions and methods for treating chronic inflammation and inflammatory diseases

granted A61KA61K31/19A61K31/192

Quick answer

US patent 10653778 (Compositions and methods for treating chronic inflammation and inflammatory diseases) held by Infirst Healthcare Limited expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Infirst Healthcare Limited
Grant date
Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/19, A61K31/192, A61K31/202, A61K31/25